Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2017 | An overview of the current treatment landscape of non-Hodgkin lymphoma

Franco Cavalli • 14 Jun 2017
ICML 2017
B-Cell Lymphoma Non-Hodgkin Lymphoma

Franco Cavalli, MD, FRCP, from the Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, President of the International Conference on Malignant Lymphoma (ICML) 2017 held in Lugano, Switzerland, gives an overview of the current treatment landscape of non-Hodgkin lymphoma. Prof. Cavalli describes the tremendous progress made in the treatment of lymphoma over recent years, taking it from an incurable disease to a treatable condition. Discussing the various disease subtypes, Prof. Cavalli talks about the clinical challenges and the various treatments available. Looking to the future, novel therapies and precision medicine are the ways forward in the treatment of non-Hodgkin lymphoma.
This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.

More from Franco Cavalli

3:56
Advances in treating T-cell lymphoma
Franco Cavalli • 24 Jun 2021
4:34
Highlights of ICML 2021
Franco Cavalli • 24 Jun 2021
5:40
Developments in B-cell lymphoma management
Franco Cavalli • 24 Jun 2021
4:13
Treating lymphoma in the developing world
Franco Cavalli • 24 Jun 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals